Consensus Cloud Solutions Announces Pricing Of Secondary Offering Of 500K Shares Held By Ziff Davis
Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) (the "Company" or "Consensus") announced today the pricing of an underwritten offering of 500,000 shares of its common stock currently owned by Ziff
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
POINT Biopharma Global Inc (NASDAQ:PNT) priced its public offering of 13.9 million shares at $9.00 per share, with gross proceeds…
After One Year Of Regulatory Hold, Larimar’s Ataxia Candidate Sees Some Hope
The FDA has cleared the initiation of Larimar Therapeutics Inc’s (NASDAQ:LRMR) 25 mg cohort of Phase 2 trial of CTI-1601 in Friedreich’s…
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on access needs for veterans.
Edgewise Therapeutics Announces Proposed $100M Offering Of Common Stock
BOULDER, Colo.--(BUSINESS WIRE)-- Edgewise Therapeutics, Inc., (NASDAQ:EWTX) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering of $100 million of its common
Relay Therapeutics Priced ~11.32M Share Public Offering of Common Stock @$26.50/Share
Relay Therapeutics, Inc. (Nasdaq: RLAY) announcedthe pricing of an underwritten public offering of 11,320,755 shares of its common stock at a public offering price of $26.50 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 1,698,113 shares of its common stock.
Revance Therapeutics Priced Upsized 8M Sharw Public Offering of Common Stock @$25/Share
Revance Therapeutics, Inc. (Nasdaq: RVNC) announced the pricing of an upsized underwritten public offering of 8,000,000 shares of its common stock. The shares of common stock are being offered at a public offering price of $25.00 per share. All of the shares are being offered by Revance.